Given the effects of ESE-1 KD on reducing the transformed phenotype in two HER2+ breast cancer cell lines, we next sought to determine whether ESE-1 knockdown could inhibit xenograft tumor formation of BT474 cells in NOD.SCID mice. Here, ERBB2 is linked to breast carcinoma.